{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T02:01:53Z","timestamp":1791597713137,"version":"4.3.4"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100020060","name":"Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization","doi-asserted-by":"publisher","award":["ZDXM-2-4"],"award-info":[{"award-number":["ZDXM-2-4"]}],"id":[{"id":"10.13039\/501100020060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007956","name":"Nanjing University of Chinese Medicine","doi-asserted-by":"publisher","award":["CX201502"],"award-info":[{"award-number":["CX201502"]}],"id":[{"id":"10.13039\/501100007956","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012246","name":"Priority Academic Program Development of Jiangsu Higher Education Institutions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81173515"],"award-info":[{"award-number":["81173515"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012154","name":"Graduate Research and Innovation Projects of Jiangsu Province","doi-asserted-by":"publisher","award":["KYLX16-1163"],"award-info":[{"award-number":["KYLX16-1163"]}],"id":[{"id":"10.13039\/501100012154","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.biopha.2017.12.047","type":"journal-article","created":{"date-parts":[[2017,12,27]],"date-time":"2017-12-27T09:18:21Z","timestamp":1514366301000},"page":"382-389","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Inhibition of p38 and ERK1\/2 pathways by Sparstolonin B suppresses inflammation-induced melanoma metastasis"],"prefix":"10.1016","volume":"98","author":[{"given":"Ya-Min","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-Yun","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing-Yu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shui-Hua","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Ao","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-Nan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiao-Li","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2017.12.047_bib0005","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nrc1098","article-title":"The pathogenesis of cancer metastasis: the \u2018seed and soil\u2019 hypothesis revisited","volume":"3","author":"Fidler","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2017.12.047_bib0010","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nrc3611","article-title":"Inflammation-induced cancer: crosstalk between tumours, immune cells andmicroorganisms","volume":"13","author":"Elinav","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2017.12.047_bib0015","doi-asserted-by":"crossref","first-page":"149185","DOI":"10.1155\/2014\/149185","article-title":"Chronic inflammation and cytokines in the tumor microenvironment","volume":"2014","author":"Landskron","year":"2014","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.biopha.2017.12.047_bib0020","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/ni.1863","article-title":"The role of pattern-recognition receptors in innate immunity: update on toll-like receptors","volume":"11","author":"Kawai","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.biopha.2017.12.047_bib0025","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1016\/j.cellsig.2014.07.035","article-title":"TLRs: linking inflammation and breast cancer","volume":"26","author":"Khyati","year":"2014","journal-title":"Cell Signal"},{"key":"10.1016\/j.biopha.2017.12.047_bib0030","first-page":"11","article-title":"Emerging role of toll-like receptor 4 in hepatocellular carcinoma","volume":"2","author":"Yang","year":"2015","journal-title":"J. Hepatocell. Carcinoma"},{"key":"10.1016\/j.biopha.2017.12.047_bib0035","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/sj.bjc.6605558","article-title":"High expression of toll-like receptor 4\/myeloid differentiation factor 88 signals correlates with poor prognosis in colorectal cancer","volume":"102","author":"Wang","year":"2010","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.biopha.2017.12.047_bib0040","doi-asserted-by":"crossref","first-page":"26470","DOI":"10.1074\/jbc.M111.227934","article-title":"Characterization of sparstolonin B, a Chinese herb-derived compound, as a selective toll-like receptor antagonist with potent anti-inflammatory properties","volume":"286","author":"Liang","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2017.12.047_bib0045","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.cyto.2014.12.003","article-title":"Protective effects of sparstolonin B, a selective TLR2 and TLR4 antagonist, on mouse endotoxin shock","volume":"75","author":"Liang","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.biopha.2017.12.047_bib0050","doi-asserted-by":"crossref","first-page":"e004340","DOI":"10.1161\/JAHA.116.004340","article-title":"Interleukin-23 secreted by activated macrophages drives cdT cell production of interleukin-17 to aggravate secondary injury after intracerebral hemorrhage","volume":"5","author":"Zhong","year":"2016","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.biopha.2017.12.047_bib0055","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ejphar.2015.10.050","article-title":"Sparstolonin B inhibits lipopolysaccharide- induced inflammation in 3T3-L1adipocytes","volume":"769","author":"Wang","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2017.12.047_bib0060","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.mehy.2013.06.034","article-title":"TAK-242 can be the potential agents for preventing invasion and metastasis of hepatocellular carcinoma","volume":"81","author":"Yu","year":"2013","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.biopha.2017.12.047_bib0065","doi-asserted-by":"crossref","first-page":"e109980","DOI":"10.1371\/journal.pone.0109980","article-title":"Toll-like receptor 4 prompts human breast cancer cells invasiveness via lipopolysaccharide stimulation and is overexpressed in patients with lymph node metastasis","volume":"9","author":"Yang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2017.12.047_bib0070","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nrc865","article-title":"Dissemination and growth of cancer cells in metastatic sites","volume":"2","author":"Chambers","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2017.12.047_bib0075","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.canlet.2016.06.014","article-title":"inhibition of the NF-\u03baB pathway by nafamostat mesilate suppresses colorectal cancer growth and metastasis","volume":"380","author":"Lu","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2017.12.047_bib0080","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.molimm.2015.10.015","article-title":"Toll-like receptor 4 signaling promotes invasion of hepatocellular carcinoma cells through MKK4\/JNK pathway","volume":"68","author":"Dong","year":"2015","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.biopha.2017.12.047_bib0085","doi-asserted-by":"crossref","first-page":"19472","DOI":"10.1074\/jbc.M414221200","article-title":"BIRB796 inhibits all p38 MAPK isoforms in vitro and in vivo","volume":"280","author":"Kuma","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2017.12.047_bib0090","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1042\/bj20020372","article-title":"Cell-cycle arrest by PD184352 requires inhibition of extracellular signal-regulated kinases (ERK) 1\/2 but not ERK5\/ BMK1","volume":"366","author":"Squires","year":"2005","journal-title":"Biochem. J."},{"key":"10.1016\/j.biopha.2017.12.047_bib0095","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3390\/cancers3010126","article-title":"Decoding melanoma metastasis","volume":"3","author":"Damsky","year":"2010","journal-title":"Cancers"},{"key":"10.1016\/j.biopha.2017.12.047_bib0100","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s10434-000-0262-z","article-title":"D. 4th. guerry, et al, incidence of sentinel node metastasis in patients with thin primary melanoma (< or = 1 mm) with vertical growth phase","volume":"7","author":"Bedrosian","year":"2000","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.biopha.2017.12.047_bib0105","doi-asserted-by":"crossref","first-page":"e6520","DOI":"10.1371\/journal.pone.0006520","article-title":"Blocking TLR2 activity attenuates pulmonary metastases of tumor","volume":"4","author":"Yang","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2017.12.047_bib0110","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1620\/tjem.234.57","article-title":"Toll-like receptor 4 signaling promotes the migration of human melanoma cells","volume":"234","author":"Takazawa","year":"2014","journal-title":"Tohoku J. Exp. Med."},{"key":"10.1016\/j.biopha.2017.12.047_bib0115","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1684\/ejd.2011.1526","article-title":"TLR expression in human melanoma cells","volume":"21","author":"Saint-Jean","year":"2011","journal-title":"Eur. J. Dermatol."},{"key":"10.1016\/j.biopha.2017.12.047_bib0120","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1189\/jlb.0304127","article-title":"Endogenous ligands of toll-like receptors","volume":"76","author":"Tsan","year":"2004","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.biopha.2017.12.047_bib0125","first-page":"187","volume":"8","author":"Mukherjee","year":"2014"},{"key":"10.1016\/j.biopha.2017.12.047_bib0130","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nrm3904","article-title":"Remodelling the extracellular matrix indevelopment and disease","volume":"15","author":"Bonnans","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.biopha.2017.12.047_bib0135","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s13402-012-0080-x","article-title":"MMP2 expression is a prognostic marker forprimary melanoma patients","volume":"35","author":"Rotte","year":"2012","journal-title":"Cell. Oncol."},{"key":"10.1016\/j.biopha.2017.12.047_bib0140","series-title":"Cutaneous Melanoma","author":"Balch","year":"2003"},{"key":"10.1016\/j.biopha.2017.12.047_bib0145","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0022-5223(19)34957-8","article-title":"Analysis of 945 cases of pulmonary metastatic melanoma","volume":"103","author":"Harpole","year":"1992","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.biopha.2017.12.047_bib0150","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.archoralbio.2016.08.011","article-title":"Insulin-like growth factor 1 promotes the proliferation and committed differentiation of human dental pulp stem cells through MAPK pathways","volume":"72","author":"Lv","year":"2016","journal-title":"J. Arch. Oral Biol."},{"key":"10.1016\/j.biopha.2017.12.047_bib0155","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1152\/physrev.1999.79.1.143","article-title":"Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human","volume":"79","author":"Widmann","year":"1999","journal-title":"J. Physiol. Rev."},{"key":"10.1016\/j.biopha.2017.12.047_bib0160","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.1002\/cam4.946","article-title":"Rap1A promotes ovarian cancer metastasis via activation of ERK\/p38 and notch signaling","volume":"5","author":"Lu","year":"2016","journal-title":"Cancer Med."},{"key":"10.1016\/j.biopha.2017.12.047_bib0165","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.3892\/or.2016.5192","article-title":"TIPE2 suppresses the tumorigenesis, growth and metastasis of breast cancer via inhibition of the AKT and p38 signaling pathways","volume":"36","author":"Zhang","year":"2016","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.biopha.2017.12.047_bib0170","article-title":"Chimaphilin inhibits human osteosarcoma cells invasion and metastasis through suppressing the TGF-\u03b21-induced epithelial-to-mesenchymal transition markers via PI-3K\/Akt, ERK1\/2 and Smad signaling pathways","author":"Dong","year":"2017","journal-title":"Can. J. Physiol. Pharmacol."}],"updated-by":[{"DOI":"10.1016\/j.biopha.2023.115616","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000}},{"DOI":"10.1016\/j.biopha.2025.118890","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000}}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217348503?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217348503?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T23:51:00Z","timestamp":1768953060000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332217348503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":34,"alternative-id":["S0753332217348503"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2017.12.047","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of p38 and ERK1\/2 pathways by Sparstolonin B suppresses inflammation-induced melanoma metastasis","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2017.12.047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}